Human DYRK4 adenoviral particles

The Dual Specificity Tyrosine Phosphorylation Regulated Kinase 4 (DYRK4) gene encodes a member of the DYRK protein kinase family, which plays a critical role in processes such as cell proliferation, differentiation, and apoptosis. DYRK4 is characterized by its ability to phosphorylate both serine/threonine and tyrosine residues, which makes it a versatile regulator in signaling pathways. This kinase has been implicated in a variety of physiological and pathological states, including neurodevelopment, cancer progression, and metabolic regulation. Studies have shown that DYRK4 may affect cell cycle regulation and stress responses, making it a potential target for therapeutic intervention.

Human DYRK4 Adenoviral Particles are genetically engineered viral vectors designed to deliver the DYRK4 gene to target cells for functional studies or therapeutic purposes. These particles are derived from a replication-defective adenovirus, which ensures efficient transduction while minimizing the risks associated with viral replication. This adenoviral system has high transduction efficiencies in a variety of cell types, including dividing and non-dividing cells, making it a valuable tool for gene overexpression experiments. Human DYRK4 adenoviral particles enable researchers to study the role of DYRK4 in cellular pathways, disease models, or drug screening assays. In addition, these particles can be used in gene therapy studies to modulate the expression of DYRK4 in specific tissues.